ChristinaLaurenFanolaMDMSc

PubMed

• 21 citations
  Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism.
  Catalin Toma, Wissam A Jaber, Mitchell D Weinberg, Matthew C Bunte, Sameer Khandhar, Brian Stegman, Sreedevi Gondi, Jeffrey Chambers, Rohit Amin, Daniel A Leung, Herma...> ;Eurointervention. 2023 Feb 20
• 11 citations
  Moderate Versus Deep Hypothermia in Type A Acute Aortic Dissection Repair: Insights from the International Registry of Acute Aortic Dissection.
  Stevan S. Pupovac, Jonathan M. Hemli, Joseph E. Bavaria, Himanshu J. Patel, Santi Trimarchi, Davide Pacini, Raffi Bekeredjian, Edward P. Chen, Truls Myrmel, Maral Ouzo...> ;The Annals of Thoracic Surgery. 2021 Jan 27
• 41 citations
  Clinical Features and Outcomes of Pregnancy-Related Acute Aortic Dissection
  Alan C. Braverman, Eric Mittauer, Kevin M. Harris, Arturo Evangelista, Reed E. Pyeritz, Derek R. Brinster, Lori D. Conklin, Toru Suzuki, Christina L. Fanola, Maral Ouz...> ;JAMA Cardiology. 2020 Oct 14
• Adult Langerhans histiocytosis with rare BRAF mutation complicated by massive pulmonary embolism.
  Salma Hassan, Christina Fanola, Amy Beckman, Faqian Li, Andrew C. Nelson, Michael A. Linden, Joan D. Beckman> ;Thrombosis Research. 2020 Jul 25
• 36 citations
  Incident Heart Failure and Long-Term Risk for Venous Thromboembolism
  Christina L. Fanola, Faye L. Norby, Amil M. Shah, Patricia P. Chang, Pamela L. Lutsey, Wayne D. Rosamond, Mary Cushman, Aaron R. Folsom> ;Journal of the American College of Cardiology. 2020 Jan 21
• 29 citations
  Decreased mortality with local versus general anesthesia in endovascular aneurysm repair for ruptured abdominal aortic aneurysm in the Vascular Quality Initiative data...
  Rumi Faizer, Eric D. Weinhandl, Selma El Hag, Stacey Le Jeune, Ioanna Apostolidou, Susan M. Shafii, Cheong J. Lee, Michael S. Rosenberg, Amy B. Reed, Christina L. Fanola> ;Journal of Vascular Surgery. 2019 Jul 1
• 131 citations
  Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium
  Belinda Rivera-Lebron, Michael C. McDaniel, Kamran Ahrar, Abdulah Alrifai, David M. Dudzinski, Christina L. Fanola, Danielle Blais, David M. Janicke, Roman Melamed, Ke...> ;Clinical and Applied Thrombosis/hemostasis. 2019 Jun 11
• 4 citations
  Vascular Genetics: Presentations, Testing, and Prognostics.
  Aaron W. Aday, Sarah Kreykes, Christina L. Fanola> ;Current Treatment Options in Cardiovascular Medicine. 2018 Nov 13
• 156 citations
  Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
  Erin A. Bohula, Stephen D. Wiviott, Darren K. McGuire, Silvio E. Inzucchi, Julia F Kuder, KyungAh Im, Christina L. Fanola, Arman Qamar, Conville Brown, Andrzej Budaj, ...> ;The New England Journal of Medicine. 2018 Aug 26
• 88 citations
  Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial.
  Christina L. Fanola, Christian T. Ruff, Sabina A. Murphy, James Jin, Anil Duggal, Noe A. Babilonia, Piyamitr Sritara, Michele Mercuri, Pieter W. Kamphuisen, Elliott M....> ;Journal of the American Heart Association. 2018 Aug 21
• 2 citations
  TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation.
  Alejandro Isidoro Pérez Cabeza, Rafael Bravo Marqués, Pedro Antonio Chinchurreta Capote, Francisco Ruiz Mateas, Christina L. Fanola, Gabriel Rosas Cervantes, José Anto...> ;Clinical Cardiology. 2018 Aug 20
• 10 citations
  Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIM...
  Erin A. Bohula, Benjamin M. Scirica, Christina L. Fanola, Silvio E. Inzucchi, Anthony C Keech, Darren K. McGuire, Steven R. Smith, Tim Abrahamsen, Bruce Francis, Wenfe...> ;American Heart Journal. 2018 Mar 29
• Society updates.
  Fanola, C.,Kanthi, Y.,Barnes, G.,Hamburg, N.> ;Vasc Med. 2018 Jul 27
• 40 citations
  Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
  Brian A. Bergmark, Benjamin M. Scirica, Ph. Gabriel Steg, Christina L. Fanola, Yared Gurmu, Ofri Mosenzon, Avivit Cahn, Itamar Raz, Deepak L. Bhatt, Savor-Timi Investi...> ;European Heart Journal. 2018 Jun 21
• 90 citations
  Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapla...
  Christina L. Fanola, David A. Morrow, Christopher P. Cannon, Petr Jarolim, Mary Ann Lukas, Christoph Bode, Judith S. Hochman, Erica L. Goodrich, Eugene Braunwald, Mich...> ;Journal of the American Heart Association. 2017 Oct 24
• 19 citations
  Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.
  Christina L. Fanola, Deirdre M. Mooney, Andrew J. Cowan, Darae Ko, Emily K Sisson, Lori E. Henault, Yorghos Tripodis, Elaine M. Hylek> ;American Heart Journal. 2017 Feb 1
• 38 citations
  A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
  Christina L. Fanola, Robert P. Giugliano, Christian T. Ruff, Marco Trevisan, Francesco Nordio, Michele Mercuri, Elliott M. Antman, Eugene Braunwald> ;European Heart Journal. 2017 Jan 7
• 6 citations
  Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran
  Christina L. Fanola> ;Vascular Health and Risk Management. 2015 May 27
• Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms.
  Cove, C. L.,Albert, C. M.,Andreotti, F.,Badimon, L.,Van Gelder, I. C.,Hylek, E. M.> ;Thromb. Haemost.. 2013 Dec 07
• Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.
  Hylek, E. M.,Ko, D.,Cove, C. L.> ;Thromb. Haemost.. 2014 Feb 28
• 20 citations
  An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.
  Christina L. Cove, Elaine M. Hylek> ;Journal of the American Heart Association. 2013 Oct 10
• Join now to see all

Journal Articles

• Clinical Features and Outcomes of Pregnancy-Related Acute Aortic Dissection  
  Alan C Braverman, Kevin M Harris, Christina Fanola, Eric Isselbacher, JAMA Cardiology
• Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients  
  Christina L. Fanola, Darren K. McGuire, Silvio E. Inzucchi, Erin A. Bohula, The New England Journal of Medicine
• Female Sex as an Independent Risk Factor for Stroke in AF: Possible Mechanisms  
  Cove C, Albert C, Andreotti F, Gelder IC, Badimon L, Hylek EM, thromb Haemost, 12/5/2013
• An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes  
  Cove CL, Hylek EM, J Am Heart Assoc, 10/23/2013
• Join now to see all

Abstracts/Posters

• [Board 460] Persistence of Valvulopathy in the CAMELLIA-TIMI 61 Trial of Lorcaserin in Obese or Overweight Patients at Increased Cardiovascular Risk
  Christina Fanola, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019

Lectures

• Panelist: Case 4 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Case #1: A 32 Year Old Woman in Third Trimester With Type B Aortic Dissection 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019